269 related articles for article (PubMed ID: 33535851)
1. The involvement of leucine-rich α-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model.
Nakajima H; Nakajima K; Serada S; Fujimoto M; Naka T; Sano S
Mod Rheumatol; 2021 Nov; 31(6):1120-1128. PubMed ID: 33535851
[TBL] [Abstract][Full Text] [Related]
2. Leucine-rich
Honda H; Fujimoto M; Serada S; Urushima H; Mishima T; Lee H; Ohkawara T; Kohno N; Hattori N; Yokoyama A; Naka T
Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29279415
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.
Castelino FV; Seiders J; Bain G; Brooks SF; King CD; Swaney JS; Lorrain DS; Chun J; Luster AD; Tager AM
Arthritis Rheum; 2011 May; 63(5):1405-15. PubMed ID: 21305523
[TBL] [Abstract][Full Text] [Related]
5. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
[TBL] [Abstract][Full Text] [Related]
6. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
7. A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis.
Kasamatsu H; Chino T; Hasegawa T; Utsunomiya N; Utsunomiya A; Yamada M; Oyama N; Hasegawa M
Arthritis Res Ther; 2023 Aug; 25(1):156. PubMed ID: 37626391
[TBL] [Abstract][Full Text] [Related]
8. Progranulin Promotes Bleomycin-Induced Skin Sclerosis by Enhancing Transforming Growth Factor-β/Smad3 Signaling through Up-Regulation of Transforming Growth Factor-β Type I Receptor.
Yang T; Zhang X; Chen A; Xiao Y; Sun S; Yan J; Cao Y; Chen J; Li F; Zhang Q; Huang K
Am J Pathol; 2019 Aug; 189(8):1582-1593. PubMed ID: 31108104
[TBL] [Abstract][Full Text] [Related]
9. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI
Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895
[TBL] [Abstract][Full Text] [Related]
10. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling.
Lu J; Liu Q; Wang L; Tu W; Chu H; Ding W; Jiang S; Ma Y; Shi X; Pu W; Zhou X; Jin L; Wang J; Wu W
Lab Invest; 2017 May; 97(5):591-601. PubMed ID: 28263294
[TBL] [Abstract][Full Text] [Related]
13. CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
Shimada S; Makino K; Jinnin M; Sawamura S; Kawano Y; Ide M; Kajihara I; Makino T; Fukushima S; Ihn H
J Dermatol Sci; 2020 Dec; 100(3):183-191. PubMed ID: 33055012
[TBL] [Abstract][Full Text] [Related]
14. The compound LG283 inhibits bleomycin-induced skin fibrosis via antagonizing TGF-β signaling.
Utsunomiya A; Chino T; Kasamatsu H; Hasegawa T; Utsunomiya N; Luong VH; Matsushita T; Sasaki Y; Ogura D; Niwa SI; Oyama N; Hasegawa M
Arthritis Res Ther; 2022 Apr; 24(1):94. PubMed ID: 35488265
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
Ohashi T; Yamamoto T
Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
[TBL] [Abstract][Full Text] [Related]
16. Antifibrotic effects and mechanisms of mesenchymal stem cell-derived exosomes in a systemic sclerosis mouse model: Possible contribution of miR-196b-5p.
Baral H; Uchiyama A; Yokoyama Y; Sekiguchi A; Yamazaki S; Amalia SN; Inoue Y; Ogino S; Torii R; Hosoi M; Matsuzaki T; Motegi SI
J Dermatol Sci; 2021 Oct; 104(1):39-47. PubMed ID: 34479773
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of bleomycin-induced pulmonary fibrosis via TGF-β-induced Smad and non-Smad signaling pathways in galectin-9-deficient mice and fibroblast cells.
Hsu YA; Chang CY; Lan JL; Li JP; Lin HJ; Chen CS; Wan L; Liu FT
J Biomed Sci; 2020 Jan; 27(1):24. PubMed ID: 31937306
[TBL] [Abstract][Full Text] [Related]
18. In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis.
Fineschi S; Bongiovanni M; Donati Y; Djaafar S; Naso F; Goffin L; Argiroffo CB; Pache JC; Dayer JM; Ferrari-Lacraz S; Chizzolini C
Am J Respir Cell Mol Biol; 2008 Oct; 39(4):458-65. PubMed ID: 18458239
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.
Lakos G; Takagawa S; Chen SJ; Ferreira AM; Han G; Masuda K; Wang XJ; DiPietro LA; Varga J
Am J Pathol; 2004 Jul; 165(1):203-17. PubMed ID: 15215176
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome analysis reveals key genes modulated by ALK5 inhibition in a bleomycin model of systemic sclerosis.
Decato BE; Ammar R; Reinke-Breen L; Thompson JR; Azzara AV
Rheumatology (Oxford); 2022 Apr; 61(4):1717-1727. PubMed ID: 34289031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
